InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（9 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
9
T+90 胜率
0%
T+90 平均收益
-6.8%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the detailed record of transactions filed by Skynner Michael, 首席技术官. Officer active across 1 company, notably BICYCLE THERAPEUTICS plc. Cumulatively, 14 reports have been logged. Split: 0 buy · 9 sells. Total volume traded: €101k. History available since 3 January 2022. The latest transaction was disclosed on 2 July 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
申报14 总计
1,859 股@ US$4.270.0027% mcap6.9% 占其流量Ordinary SharesSEC:0001776582-26-000006:0
532 股@ US$4.310.0008% mcap2.0% 占其流量Ordinary SharesSEC:0001776582-26-000006:1
814 股@ US$8.026.5% 占其流量Ordinary SharesSEC:0001415889-25-010244:0
35,000 股0Ordinary SharesSEC:0001415889-25-000923:0
972 股@ US$22.2621.4% 占其流量Ordinary SharesSEC:0001415889-24-024770:0
967 股@ US$19.6419.2% 占其流量Ordinary SharesSEC:0001415889-24-019388:0
955 股@ US$23.8122.9% 占其流量Ordinary SharesSEC:0001415889-24-010417:0
28,000 股0Ordinary SharesSEC:0001209191-24-000876:0
442 股@ US$20.009.2% 占其流量Ordinary SharesSEC:0001209191-23-052248:0
451 股@ US$25.1011.3% 占其流量Ordinary SharesSEC:0001209191-23-041574:0
447 股@ US$21.119.4% 占其流量Ordinary SharesSEC:0001209191-23-023350:0
17,500 股0Ordinary SharesSEC:0001209191-23-002198:0
15,000 股0Ordinary SharesSEC:0001209191-22-001823
15,000 股0Ordinary SharesSEC:0001209191-22-001823:0
14 条申报中的 14 条
About Skynner Michael
Michael Skynner serves as the Chief Technology Officer at Bicycle Therapeutics plc. In this role, he is responsible for the company's technological direction, ensuring that innovations support strategic objectives. His expertise in biotechnology and ability to lead technical teams are essential for the development of new products. He plays a key role in the continuous improvement of the company's systems and processes.
